This study, called INSPIRE, is looking at how including patient information in tumor board meetings affects treatment decisions for people with breast, gynecologic (corpus uteri, ovary, other female genital), or pancreatic cancer. Tumor boards are meetings where a team of doctors discusses your case to decide on the best treatment plan. The INSPIRE intervention involves systematically sharing your patient-reported information, like your preferences, how far you live from care, and a geriatric assessment (a check-up for older adults), with the tumor board. Researchers want to see if this leads to changes in treatment, how much healthcare you use, and your overall well-being. You may be able to join if you are 18 or older and have a recent diagnosis of one of these cancers.

Study design

This study includes an initial observational part followed by a randomized controlled trial. It aims to enroll 2748 participants.

What's involved

If you participate, you will complete questionnaires about your health, daily function, and preferences at the start, and again at 3 and 6 months. These can be done online, by phone, on a tablet, or on paper.

Compensation

Not stated in the trial record.

Follow-up

The study measures treatment changes from the tumor board presentation up to 3 months later. You will complete questionnaires for 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.